HIGHLAND CAPITAL MANAGEMENT LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 128 filers reported holding TG THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$7,391,000
+4.6%
854,360
-2.7%
0.43%
-1.8%
Q1 2019$7,063,000
+279.9%
878,360
+93.7%
0.44%
+207.7%
Q4 2018$1,859,000
-55.9%
453,360
-39.8%
0.14%
-38.6%
Q3 2018$4,218,000
-31.6%
753,151
+60.5%
0.23%
-33.4%
Q2 2018$6,171,000
-6.4%
469,241
+1.0%
0.35%
+2.9%
Q1 2018$6,595,000464,3910.34%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders